Manufacturer record
Regent Ajanta Biotech: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
6 batches manufactured by Regent Ajanta Biotech (Uttarakhand) were declared Not of Standard Quality between January 2025 and June 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: PRT2512-47, Telmisartan 40mg & Amlodipine Besylate Tablets IP 5mg (exp Nov 2027). SDTL, Guwahati (state lab) found it not of standard quality: The sample does not conform to I.P. w.r.to the tests for Dissolution. Listed in the June 2026 alert.
Records by type
6 records linked to Regent Ajanta Biotech in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Telmisartan 40mg & Amlodipine Besylate Tablets IP 5mg | Batch PRT2512-47Mfg Dec 2025 · Exp Nov 2027 | The sample does not conform to I.P. w.r.to the tests for DissolutionDissolution | SDTL, GuwahatiState lab | Jun 2026 |
| Levocetirizine Dihydrochloride Tablets IP 5mg | Batch PRT2501-149Mfg Jan 2025 · Exp Dec 2026 | The sample does not conform to standard quality in respect of the test for Description performed.Description | SDTL, Tripura, AgartalaState lab | Jun 2026 |
| Paracetamol, Phenylephrine Hydrochloride & Chlorpheniramine Maleate Suspension125mg/5mg/1mg (60ml) | Batch PRL2501-03Mfg Jan 2025 · Exp Dec 2026 | The sample received does not conform to Manufacturers specification with respect to the test for Description and Assay of Phenyleprhine hydrochloride.Assay | CDTL, MumbaiCDSCO lab | Apr 2026 |
| Sucralfate & Oxetacaine Oral Suspension(Sucrakars- O Suspension) | Batch RL2412-10Mfg Dec 2024 · Exp Nov 2026 | Assay of SucralfateAssay | CDL, KolkataCDSCO lab | Jul 2025 |
| Luliconazole Cream IP 1% w/w | Batch 2946Mfg May 2024 · Exp Apr 2026 | sample does not Conform to IP Specification for Luliconazole Cream with respect to the PH of 10% w/v solution.pH | DTL MaduraiState lab | Jan 2025 |
| Aceclofenac & Drotaverine Hydrochlori de Tablets (100 mg/ 80 mg) | Batch PRT2401, -01Mfg Jan 2024 · Exp Dec 2025 | DescriptionDescription | State Lab KarnatakaState lab | Jan 2025 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.